Search

Your search keyword '"Ambrosio, Maria Raffaella"' showing total 6 results
Start Over Author "Ambrosio, Maria Raffaella" Publisher mdpi ag
6 results on '"Ambrosio, Maria Raffaella"'

1. Paving the Path for Immune Enhancing Nutrition in Colon Cancer: Modulation of Tumor Microenvironment and Optimization of Outcomes and Costs

Author

Ambrosio, Maria Raffaella, primary, Spagnoli, Luigi, additional, Perotti, Bruno, additional, Petrelli, Federica, additional, Caini, Saverio, additional, Saieva, Calogero, additional, Usai, Sofia, additional, Bianchini, Matteo, additional, Cavazzana, Andrea, additional, Arganini, Marco, additional, and Amorosi, Andrea, additional

Published
2023
Full Text
View/download PDF

2. Immunohistochemical Markers of the Epithelial-to-Mesenchymal Transition (EMT) Are Related to Extensive Lymph Nodal Spread, Peritoneal Dissemination, and Poor Prognosis in the Microsatellite-Stable Diffuse Histotype of Gastric Cancer

Author

Marrelli, Daniele, primary, Marano, Luigi, additional, Ambrosio, Maria Raffaella, additional, Carbone, Ludovico, additional, Spagnoli, Luigi, additional, Petrioli, Roberto, additional, Ongaro, Alessandra, additional, Piccioni, Stefania, additional, Fusario, Daniele, additional, and Roviello, Franco, additional

Published
2022
Full Text
View/download PDF

3. hERG1 Potassium Channel Expression in Colorectal Adenomas: Comparison with Other Preneoplastic Lesions of the Gastrointestinal Tract

Author

Lastraioli, Elena, primary, Iorio, Jessica, additional, Petrelli, Federica, additional, Tomezzoli, Anna, additional, Battista, Serena, additional, Ambrosio, Maria Raffaella, additional, Chiudinelli, Mariella, additional, De Salvatore, Federica, additional, Messerini, Luca, additional, Villanacci, Vincenzo, additional, Saragoni, Luca, additional, and Arcangeli, Annarosa, additional

Published
2022
Full Text
View/download PDF

6. Immune Modulation by Epstein-Barr Virus Lytic Cycle: Relevance and Implication in Oncogenesis.

Author

Todorović N, Ambrosio MR, and Amedei A

Abstract

EBV infects more than 90% of people globally, causing lifelong infection. The phases of the EBV life cycle encompass primary infection, latency, and subsequent reactivation or lytic phase. The primary infection usually happens without noticeable symptoms, commonly in early life stages. If it manifests after childhood, it could culminate in infectious mononucleosis. Regarding potential late consequences, EBV is associated with multiple sclerosis, rheumatoid arthritis, chronic active EBV infection, lymphomas, and carcinomas. Previous reports that the lytic phase plays a negligible or merely secondary role in the oncogenesis of EBV-related tumors are steadily losing credibility. The right mechanisms through which the lytic cycle contributes to carcinogenesis are still unclear, but it is now recognized that lytic genes are expressed to some degree in different cancer-type cells, implicating their role here. The lytic infection is a persistent aspect of virus activity, continuously stimulating the immune system. EBV shows different strategies to modulate and avoid the immune system, which is thought to be a key factor in its ability to cause cancer. So, the principal goal of our review is to explore the EBV's lytic phase contribution to oncogenesis.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results